Results 141 to 150 of about 8,209 (210)

Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia. [PDF]

open access: yesInflamm Bowel Dis
Bocchini B   +6 more
europepmc   +1 more source

JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology. [PDF]

open access: yesMedicina (Kaunas)
Foggi G   +7 more
europepmc   +1 more source

Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis [PDF]

open access: yes
Adult atopic dermatitis (AD), specifically late-onset phe- notypes, is characterized by a notable degree of clinical heterogeneity in terms of morphologic and topographic characteristics.
Andrea Chiricozzi   +15 more
core  

Rapid Induction of Remission With Upadacitinib Followed by Cytomegalovirus Colitis in a Hospitalized Patient With Crohn's Disease. [PDF]

open access: yesACG Case Rep J
Herran R   +14 more
europepmc   +1 more source

Benefit-risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn's disease. [PDF]

open access: yesJ Crohns Colitis
Vermeire S   +18 more
europepmc   +1 more source

Upadacitinib versus Tofacitinib in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis. [PDF]

open access: yesInflamm Intest Dis
Alsaleh T   +7 more
europepmc   +1 more source

JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study. [PDF]

open access: yesSci Rep
Zheng J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy